Carolina Reduzzi
@ReduzziCarol
Followers
336
Following
635
Media
24
Statuses
208
PhD, working on translational #CancerResearch and #LiquidBiopsies @WeillCornell Young Committee Chair @isliquidbiopsy
New York, NY, USA
Joined April 2019
Today we launched the "ISLB Global Survey: Oncologist Attitudes and Practices on Liquid Biopsy" to collect worldwide data on the use of liquid biopsy in clinical practice! Help us sharing the survey with all the oncologists you know :) https://t.co/UfwHSj5Pn3
1
27
34
New Study 👉Circulating tumor cells dynamics after CDK4/6 inhibitor for hormone-receptor positive #MetastaticBreastCancer: A biomarker analysis from the PACE phase II study. #ctDNA #MNC #BreastCancer 📎 https://t.co/8Ycb2EoZEV
@LGerratana @ReduzziCarol @RMJesel @AngieDemichele
1
23
43
Great paper from our ISLB Young Committee! A huge effort to keep sharing #LiquidBiopsy knowledge through reviews and editorials after major conferences worldwide. Follow us for more LB updates and insights! 🌍🧬 #ISLB #sciencecommunication
Our review on key advancements in #liquidbiopsy in 2024 is finally out! This work was made possible thanks to the incredible team effort of the @isliquidbiopsy Young Committee. 📰Check it out! ➡️ https://t.co/BOFNykc6NQ
0
10
23
DESTINYBreast06 at #ASCO25 suggests a greater benefit from T-DXd in BRCA1/2-mutant #MBC (HR 0.17) ‼️Small N (20 pts) 🧬 biologically plausible synergy via DNA damage. ⚠️ Still no data on key biomarkers like ERBB2 #BreastCancer #ADC #Biomarkers #PrecisionMedicine
0
4
13
If you are a young researcher with an interest in liquid biopsy, come talk to us at the @isliquidbiopsy booth at #ASCO2025 about the activities of the Young Committee and how to join! @robertobore
#ISLB at our booth with members of ISLB " Young Committee", led by amazing Carolina Reduzzi. Only at ISLB is there an organized & empowered committee of young investigators, conducting its own research, educational events, & publishes its own work. Come join us @isliquidbiopsy
0
5
7
Here with @drgandara , ISLB CMO, and some amazing members of the ISLB Young Committee! 🙌 Great to meet in person and share ideas 💡on how to keep growing together. Excited for what’s ahead! the best is yet to come! #ASCO25 @Booth12041
@ReduzziCarol @mgoudaMD
0
6
22
Super excited to share our latest review in the Journal of Liquid Biopsy on the huge impact of LB in oncology! 🩸🔬 LB is reshaping cancer care💥 👉 https://t.co/q0CUtv1n8P
@isliquidbiopsy @ReduzziCarol @OSUCCC_James @rolfolab @WeillCornell @UmbertoMalapel1 @ChristianRolfo
1
7
18
🩸👀See how @WCMEnglanderIPM is using #LiquidBiopsy to improve #PrecisionMedicine w/ @HashemAGH @GuardantHealth
https://t.co/59BkE13bl4
0
4
7
The Liquid Biopsy Platform is launching a new seminar series within the HemOnc Seminar Talk - Carolina Reduzzi (@ReduzziCarol) @WeillCornell
https://t.co/QsBXsu99Rw
#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews
oncodaily.com
Carolina Reduzzi: The Liquid Biopsy Platform is launching a new seminar series within the HemOnc Seminar Talk / cancer, Carolina Reduzzi, EIPM, Hashem
1
2
16
2025 ISLB Annual Congress, will take place in Orlando, Florida, November 1-3, 2025. This is an extraordinary gathering of scientists, clinicians, industry leaders, and innovators, all united by a shared passion for advancing liquid biopsy https://t.co/djipdLKYJX
0
16
51
The International Society of Liquid Biopsy (@isliquidbiopsy) is conducting a global survey on the use of Liquid Biopsy in clinical practice. Your input will help shape strategies to improve its implementation and effectiveness in cancer care worldwide. 🌍 @ReduzziCarol
0
10
24
Now you can find the link to complete our @isliquidbiopsy survey in the @OncoAlert newsletter! 📨 It only takes 5 min to help us understand how LB 🩸 is reshaping clinical practice worldwide! https://t.co/eUgyfeQJwz
@ReduzziCarol @ChristianRolfo @UmbertoMalapel1 @weoncologists
0
12
15
https://t.co/sJkIg7Ob7T Our meta-analysis aggregates data from more the 30 studies comprising 3000+ patients, showing that ctDNA decrease and clearance are strongly associated with PFS and OS in lung cancer. Results hold true for targeted treatments and immunotherapy! @iaslc
12
52
159
Our new #CTC review is published today via Elsevier. Congrats to the authors @youbin_zhang David Scholten, Wenan Qiang @LeonidasPlatan1 @DrWGradishar @ShanaOKelley @LurieCancer @NUFeinbergMed and @czbiohub Thanks to @ReduzziCarol and @LGerratana
https://t.co/rbLK060xRv
0
6
18
Survey Participation Request on Behalf of @isliquidbiopsy & @OncoAlert Oncologist Attitudes and Practices on Liquid Biopsy 👉 https://t.co/DiygHpXv3e This survey aims to evaluate oncologists' attitudes, practices, and barriers to the use of liquid biopsy in clinical care. Your
0
16
24
Happy to have contributed to this work showing the effect of bone metastasis on #HER2 expression and secondary metastatic dissemination in HR+/HER2- metastatic #BreastCancer Out now on @CD_AACR! @CtcLaboratory @WeillCornell @BadoIgor
https://t.co/9vsOvS38hl
1
7
29
🗓️Mark Your Calendars! Join us at FOCUS on TOP in Udine, Italy, on March 17-18, 2025! 📍 Venue: Hotel Là di Moret, Udine, Italy 🚆 Train: Udine railway station ✈️ Airports: Venice Marco Polo, Trieste - Friuli Venezia Giulia 🌐 More Info: https://t.co/Iv2GtNH6xn
0
2
4
🎤 Hear it from our speakers! On March 17, 2025, at 14:00, @ReduzziCarol will take the stage at FOCUS on TOP in the #LiquidBiopsy Session, exploring the role of circulating tumor cells (#CTCs) in #MRD monitoring with #ctDNA. Program and registration: 👇 https://t.co/6opTBEPkOX
0
7
11
You’ve heard me say that #LiquidBiopsies are here to stay. A lot of the talk is about circulating tumor DNA🧬ctDNA. Circulating Tumor Cells➖CTCs🟣🟠🔴 are another less talked about lens🔍. Intact cells➕Membrane🔬. 📕 📖 👇🏽here’s our work as a chapter/article. @OncoAlert 🧵1/
5
12
31
Survey Participation Request on Behalf of @isliquidbiopsy & @OncoAlert Oncologist Attitudes and Practices on Liquid Biopsy 👉 https://t.co/o1IaehFTZq This survey aims to evaluate oncologists' attitudes, practices, and barriers to the use of liquid biopsy in clinical care.
0
13
17
.@CtcLaboratory team members gave insights into their #research involvement on the use of circulating tumor DNA (#ctDNA) testing for both advanced and early-stage #BreastCancer at #SABCS24
0
2
6